Nutriband Inc. Common Stock (NTRB) Stock Price
NTRBStock
$4.83−20.59%52W
Market Cap$58.71M
P/E—
PEG Ratio—
Div yield—
Beta2.02
NTRB Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)16.50%
Price vs S&P 500 (4W)69.88%
VGM Score38.75
NTRB Earnings Surprise History
Q1 25-0.12est. -0.16
Q2 25-2.12est. -0.17
Q3 25-0.32est. -2.13
Q4 25-0.04est. -1.89
NTRB Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.14
4.14
4.14
4.14
Industry Peers — Orthopedic & Prosthetic Devices(33)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
NTRBNutriband Inc. Common Stock | F | D | B | $4.83 |
| ISRGIntuitive Surgical Inc. | D | B | D | $371.84 |
| EWEdwards Lifesciences Corp | D | C | B | $90.87 |
| STESTERIS plc | C | B | C | $236.44 |
| ZBHZimmer Biomet Holdings, Inc. | B | C | C | $100.24 |
| SNNSmith & Nephew plc | B | C | D | $29.22 |
| ALGNAlign Technology Inc | B | D | C | $159.61 |
| MSAMine Safety Incorporated | C | C | C | $187.69 |
| ESTAEstablishment Labs Holdings Inc. | F | A | C | $72.15 |
| ENOVEnovis Corporation | B | D | C | $25.58 |
| CDRECadre Holdings, Inc. | C | C | C | $31.39 |
About Nutriband Inc. Common Stock
Nutriband Inc develops transdermal pharmaceutical products designed to prevent drug abuse and diversion. The company's proprietary AVERSA technology incorporates aversive agents into pharmaceutical formulations to reduce the risk of opioid abuse and misuse. Revenue is generated through the sale of consumer transdermal and coated pharmaceutical products.